This real-world study is a description and summary of the clinical data of children with ERA in our hospital, so this study not only confirms the effectiveness of tumor necrosis factor inhibitors in children with ERA, but also provides more evidence for precision diagnosis and treatment for other hospitals, families and patients. This evidence concerns the gene TNF and enthesitis-related juvenile idiopathic arthritis.